Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of June 2018
Filing Date: June 29, 2018
This filing serves as a cover document to furnish a press release issued on June 28, 2018, to the U.S. Securities and Exchange Commission. The registrant is a partnership limited by shares based in Bad Homburg, Germany.
Key Financial Metrics
The provided filing text does not contain specific financial data. It acts solely as a transmission vehicle for an external press release (Exhibit 99.1). Consequently, the following metrics are not available in this document:
- Revenue: Not provided in filing text.
- Profit: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not disclose specific material changes, financial comparisons, or operational updates versus prior periods. Investors must refer to the attached Exhibit 99.1 (Press Release) for details on any material events.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed within the body of this Form 6-K. The document contains only administrative signatures and exhibit listings.
Investor Verification Checklist
- Review Exhibit 99.1: The core information regarding the company's status is contained in the press release issued on June 28, 2018, which is not included in the provided text.
- Confirm Filing Status: Verify that the registrant files annual reports under Form 20-F (indicated as "Yes" in the filing).
- Check for Rule 12g3-2(b): Note that the registrant indicated "No" regarding furnishing information pursuant to Rule 12g3-2(b).
- Identify Signatories: The report was signed by Rice Powell (CEO) and Michael Brosnan (CFO) on behalf of the General Partner.